Capricor Therapeutics (CAPR) Short-term Investments (2016 - 2025)
Historic Short-term Investments for Capricor Therapeutics (CAPR) over the last 12 years, with Q3 2025 value amounting to $79.1 million.
- Capricor Therapeutics' Short-term Investments rose 37477.35% to $79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.1 million, marking a year-over-year increase of 37477.35%. This contributed to the annual value of $140.2 million for FY2024, which is 46560.22% up from last year.
- Latest data reveals that Capricor Therapeutics reported Short-term Investments of $79.1 million as of Q3 2025, which was up 37477.35% from $99.6 million recorded in Q2 2025.
- Capricor Therapeutics' Short-term Investments' 5-year high stood at $140.2 million during Q4 2024, with a 5-year trough of $16.7 million in Q3 2024.
- Its 4-year average for Short-term Investments is $51.1 million, with a median of $34.1 million in 2023.
- Per our database at Business Quant, Capricor Therapeutics' Short-term Investments crashed by 4885.63% in 2023 and then soared by 46560.22% in 2024.
- Capricor Therapeutics' Short-term Investments (Quarter) stood at $31.8 million in 2022, then decreased by 22.08% to $24.8 million in 2023, then surged by 465.6% to $140.2 million in 2024, then plummeted by 43.62% to $79.1 million in 2025.
- Its Short-term Investments was $79.1 million in Q3 2025, compared to $99.6 million in Q2 2025 and $116.0 million in Q1 2025.